fig1

Progress in the treatment of NK-cell lymphoma/leukemia

Figure 1. Treatment flowchart of ENKL patients. *CCRT-VIPD and CCRT-VIDL regimens are included. AspaMetDex regimen is included only in relapsed or refractory ENKL patients. The definition of limited stage in this flowchart is a little different from that in the conventional Lugano/Ann Arbor classification. UAT: Upper aerodigestive tract; LN: lymph node; RT: radiotherapy; DeVIC: dexamethasone, etoposide, ifosfamide, carboplatin; CR: complete response; PR: partial response; PD: progressive disease; SMILE: steroid, methotrexate, ifosfamide, L-asparaginase, etoposide; L-asp: L-asparaginase; HSCT: hematopoietic stem cell transplantation.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/